Hyponatraemia and cancer

This publication has 89 references indexed in Scilit:

• Water and electrolyte abnormalities in novel pharmacological agents for kidney disease and cancer
  Clinical and Experimental Nephrology, 2025
• COVID-19-induced neurological symptoms: focus on the role of metal ions
  Inflammopharmacology, 2023
• MD simulation-based screening approach identified tolvaptan as a potential inhibitor of Eg5
  Molecular Diversity, 2022
• Lower Serum Sodium Levels Are Associated with the Therapeutic Effect of Sorafenib on Hepatocellular Carcinoma
  Digestive Diseases and Sciences, 2020
• Hyponatremia: pathophysiology, classification, manifestations and management
  International Urology and Nephrology, 2014
• Chronic hyponatremia exacerbates multiple manifestations of senescence in male rats
  AGE, 2012
• Indication of the Extent of Hepatectomy for Hepatocellular Carcinoma on Cirrhosis by a Simple Algorithm Based on Preoperative Variables
  Archives of Surgery, 2009
• Hyponatremia in cirrhosis: Pathogenesis, clinical significance, and management
  Hepatology, 2008
• Vasopressin antagonists
  Cellular and Molecular Life Sciences, 2006
• Binding of (3H) SR 49059, a Potent Nonpeptide Vasopressin V1a Antagonist, to Rat and Human Liver Membranes
  Biochemical and Biophysical Research Communications, 1994